Trade TTRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Turn Therapeutics Inc. (TTRX) is trading at US$12.36, down 7.28% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$287.28M. Over the past 52 weeks, TTRX has traded between US$2.57 and US$26.50. On Syfe you can trade TTRX with $0 commission and add it to your watchlist.
| Previous close | US$13.33 |
|---|---|
| Market cap | US$287.28M |
| 52-week range | US$2.57 – US$26.50 |
| Volume | 111.24K |
| Exchange | US |
Turn Therapeutics Inc.
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded by Bradley Burnam on January 6, 2015 and is headquartered in Westlake Village, CA.
Year: 2025
Turn Therapeutics Completes Interim Phase 2 Review; Expands GX-03 Study in Atopic Dermatitis
Jul 7, 12:56 PM · MT Newswires
Turn Therapeutics Inc. (TTRX) stock is trading at US$12.36, -7.28% from the previous close of US$13.33.
The market cap for Turn Therapeutics Inc. (TTRX) stock is approximately US$287.28M.
The 52-week high for Turn Therapeutics Inc. (TTRX) stock is US$26.50.
The 52-week low for Turn Therapeutics Inc. (TTRX) stock is US$2.57.
Turn Therapeutics Inc. (TTRX) does not currently pay a dividend.
Stay on top of TTRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
